View Clinical Trial (Medical Research Study)
A Preliminary Comparison of the Blood Levels of Medications in Obese Subjects Compared to Post-Gastric Bypass Subjects - NCT01015976-58103(Clinical Trial 444862)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Fargo |
|
State:
|
|
ND |
| Zip Code: |
|
58103 |
| Conditions: |
|
Gastric Bypass |
| Purpose: |
|
The purpose of this study is to determine the difference, if any, in the area under the
sertraline plasma level time curve (AUC) between patients who are nine to fifteen months
post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age
and gender.
|
| Study summary: |
|
Secondary objectives include the determination of changes in mean CPmax, Time to CPmax and
Volume of Distribution between the two groups. Also, assessment of subject tolerance of
sertraline utilizing the UKU side effect rating scale. |
| Criteria: |
|
Inclusion Criteria:
- Male or female subjects between the ages of 18 and 60 years.
- Subjects must be of good general health by history and physical exam.
- Five subjects 9 to 15 months past bariatric surgery (Roux-en-Y procedure), no BMI
requirement.
- Five subjects matched for body mass index, age and sex to the post bariatric surgery
group.
- No contraindications to receiving a single dose of 100 mg of sertraline.
- Women of child bearing potential must be practicing an accepted method of birth
control (barrier method or oral contraception) and have a negative pregnancy test at
baseline.
Exclusion Criteria:
- Allergy to sertraline or any of its constituents.
- Candidates currently receiving sertraline or any other antidepressant.
- Candidates currently receiving a medication that interacts with sertraline (Zoloft)
- Candidates who are poor metabolizers for the CYP2D6 and/or 2C19 enzymes.
- Candidates experiencing clinically significant, unstable neurological, hepatic, renal
or cardiovascular disease.
- Candidates currently or with a past history of meeting DSM-IV diagnostic criteria for
schizophrenia, schizoaffective disorder, bipolar disorder.
- Candidates who have participated in an investigational drug study in past 30 days.
- Candidates who meet DSM-IV diagnostic criteria for drug/alcohol abuse or dependency
or who have a history of drug/alcohol abuse or dependency.
- Candidates who are pregnant or nursing at time of study. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|